141 related articles for article (PubMed ID: 28375935)
21. [Evaluation of hormone therapy in women during postmenopause with the help of Kliogest].
Bałajewicz M; Mazanek-Mościcka M
Ginekol Pol; 1996 Nov; 67(11):561-8. PubMed ID: 9289443
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women.
Delgado JL; Estevez J; Radicioni M; Loprete L; Moscoso Del Prado J; Nieto Magro C
Climacteric; 2016 Apr; 19(2):172-80. PubMed ID: 26786399
[TBL] [Abstract][Full Text] [Related]
23. Estrogen therapy influence on periurethral vessels in postmenopausal incontinent women using Dopplervelocimetry analysis.
Kobata SA; Girão MJ; Baracat EC; Kajikawa M; Di Bella V; Sartori MG; Jármy-Di Bella ZI
Maturitas; 2008 Nov; 61(3):243-7. PubMed ID: 18845407
[TBL] [Abstract][Full Text] [Related]
24. Decreased neurofilament light chain levels in estriol-treated multiple sclerosis.
Voskuhl R; Kuhle J; Siddarth P; Itoh N; Patel K; MacKenzie-Graham A
Ann Clin Transl Neurol; 2022 Aug; 9(8):1316-1320. PubMed ID: 35770318
[TBL] [Abstract][Full Text] [Related]
25. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
[TBL] [Abstract][Full Text] [Related]
26. Estrogen and testosterone therapies in multiple sclerosis.
Gold SM; Voskuhl RR
Prog Brain Res; 2009; 175():239-51. PubMed ID: 19660660
[TBL] [Abstract][Full Text] [Related]
27. [Local estrogen therapy--clinical implications--2012 update].
Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
[TBL] [Abstract][Full Text] [Related]
28. [Effect of vaginal estriol on urogenital symptoms in postmenopausal women].
Hejlová P; Zivný J
Ceska Gynekol; 2004 Jul; 69(4):329-35. PubMed ID: 15369256
[TBL] [Abstract][Full Text] [Related]
29. Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.
Santen RJ; Kagan R; Altomare CJ; Komm B; Mirkin S; Taylor HS
J Clin Endocrinol Metab; 2014 Mar; 99(3):733-47. PubMed ID: 24423357
[TBL] [Abstract][Full Text] [Related]
30. Low-potency oestrogen and risk of endometrial cancer: a case-control study.
Weiderpass E; Baron JA; Adami HO; Magnusson C; Lindgren A; Bergström R; Correia N; Persson I
Lancet; 1999 May; 353(9167):1824-8. PubMed ID: 10359406
[TBL] [Abstract][Full Text] [Related]
31. Treatment of multiple sclerosis with the pregnancy hormone estriol.
Sicotte NL; Liva SM; Klutch R; Pfeiffer P; Bouvier S; Odesa S; Wu TC; Voskuhl RR
Ann Neurol; 2002 Oct; 52(4):421-8. PubMed ID: 12325070
[TBL] [Abstract][Full Text] [Related]
32. Undertreatment of menopausal symptoms and novel options for comprehensive management.
Lewis V
Curr Med Res Opin; 2009 Nov; 25(11):2689-98. PubMed ID: 19775194
[TBL] [Abstract][Full Text] [Related]
33. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women.
Torella M; Del Deo F; Grimaldi A; Iervolino SA; Pezzella M; Tammaro C; Gallo P; Rappa C; De Franciscis P; Colacurci N
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():125-128. PubMed ID: 27838537
[TBL] [Abstract][Full Text] [Related]
35. Coital pain in the elderly: could a low dose estriol gel thrill the vulvar vestibule?
Murina F; Graziottin A; Felice R; Di Francesco S
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():121-124. PubMed ID: 27838536
[TBL] [Abstract][Full Text] [Related]
36. Menopausal hormone replacement therapy.
Varner RE
Curr Womens Health Rep; 2003 Oct; 3(5):410-7. PubMed ID: 12959701
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer risk in postmenopausal women using estrogen-only therapy.
Lyytinen H; Pukkala E; Ylikorkala O
Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
[TBL] [Abstract][Full Text] [Related]
38. Does estrogen adequately protect postmenopausal women against osteoporosis: an iconoclastic perspective.
Orwoll ES; Nelson HD
J Clin Endocrinol Metab; 1999 Jun; 84(6):1872-4. PubMed ID: 10372678
[TBL] [Abstract][Full Text] [Related]
39. Risks and effectiveness of compounded bioidentical hormone therapy: a case series.
Davis R; Batur P; Thacker HL
J Womens Health (Larchmt); 2014 Aug; 23(8):642-8. PubMed ID: 25111856
[TBL] [Abstract][Full Text] [Related]
40. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
